• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Use and Misuse of Aspirin in Primary Cardiovascular Prevention.
Abstract The use of low-dose aspirin in primary prevention of cardiovascular (CV) events in healthy or apparently healthy people is a widely debated topic. Many arguments indicate that "primary prevention" is only a conventional definition and that the transition from primary to secondary prevention represents a continuum of increasing levels of CV risk. Although there are no direct proofs of a different efficacy of aspirin at different CV risk levels, in low-risk populations aspirin will appear to be less efficient. In fact, the lower number of events occurring in patients at low risk yields lower absolute number...
Source: Clinical Colorectal Cancer - May 6, 2017 Category: Cancer & Oncology Authors: Coccheri S Tags: Clin Med Insights Cardiol Source Type: research

Use and Misuse of Aspirin in Primary Cardiovascular Prevention
The use of low-dose aspirin in primary prevention of cardiovascular (CV) events in healthy or apparently healthy people is a widely debated topic. Many arguments indicate that “primary prevention” is only a conventional definition and that the transition from primary to secondary prevention represents a continuum of increasing levels of CV risk. Although there are no direct proofs of a different efficacy of aspirin at different CV risk levels, in low-risk populations aspirin will appear to be less efficient. In fact, the lower number of events occurring in patients at low risk yields lower absolute numbers of events pr...
Source: Clinical Medicine Insights: Cardiology - April 21, 2017 Category: Cardiology Authors: Sergio. Coccheri Source Type: research

Aspirin reduces cardiovascular events in primary prevention of cardiovascular disease but at a near equivalent risk of increased bleeding
Commentary on: Guirguis-Blake JM, Evans CV, Senger CA, et al.. Aspirin for the primary prevention of cardiovascular events: a systematic evidence review for the US Preventive Services Task Force. Ann Intern Med 2016;164:804–13 . Context The use of aspirin in primary prevention of cardiovascular disease (CVD) remains controversial, as randomised controlled trials (RCTs) have produced mixed results. Recently, the United States Preventive Services Task Force (USPSTF) published updated recommendations on the use of aspirin for primary prevention of CVD and colorectal cancer.1 This systematic review and meta-analysis serv...
Source: Evidence-Based Medicine - November 22, 2016 Category: Internal Medicine Authors: Miedema, M. D., Virani, S. S. Tags: Clinical trials (epidemiology), Epidemiologic studies, Drugs: cardiovascular system, Stroke, Hypertension, Ischaemic heart disease Therapeutics/Prevention Source Type: research

Can aspirin protect against cancer?
The other day, a fit 50-year-old man came to me for a visit to review his health. As we discussed his (generally good) efforts to take care of himself, he said, “I’ve been wondering if I should take an aspirin every day. I read somewhere that it can prevent cancer.” As a clinician, I really love it when people come in with questions that stretch my thinking. I have a stock set of answers to the “does aspirin prevent heart disease” question, but I didn’t have an easy answer to the cancer prevention question. What were the data? What should I be recommending? Is it true for everyone? Or maybe just for some people...
Source: New Harvard Health Information - May 20, 2016 Category: Consumer Health News Authors: Lori Wiviott Tishler, MD, MPH Tags: Cancer Drugs and Supplements Health Heart Health Prevention Source Type: news

Well: Ask Well: Taking a Daily Aspirin
Adults ages 50 to 69 who are at high risk for heart attack or stroke should take a daily low-dose aspirin to prevent both heart attacks and strokes as well colorectal cancer.
Source: NYT - May 6, 2016 Category: American Health Authors: RONI CARYN RABIN Tags: Aspirin Colon and Colorectal Cancer Heart Stroke Ask Well Featured Live Source Type: news

Daily low-dose aspirin may help combat cancer
Conclusion The systematic review looked at 47 studies and attempted to combine the results, looking for evidence of a beneficial effect of low-dose aspirin on risk of death in people already diagnosed with cancer. The few RCTs identified – the best-quality evidence – did not provide conclusive evidence that aspirin improves survival rates. The rest of the studies were observational in nature, so cannot prove that aspirin reduces the risk of death from cancer. The only significant results were for a 24% reduction in risk of death from colon cancer, and a possible 11% reduced risk of death from prostate cancer. However,...
Source: NHS News Feed - April 22, 2016 Category: Consumer Health News Tags: Cancer Medication Source Type: news

Aspirin a day may push death away, new study says
Taking an aspirin a day might help prevent heart attacks, stroke and colon cancer.
Source: CNN.com - Health - April 12, 2016 Category: Consumer Health News Source Type: news

Daily aspirin 'protects against heart attack and colon cancer' in certain patients
The US Preventative Services Task Force recommends people aged 50 to 59 who are at risk of cardiovascular disease take a daily dose of aspirin to lower their risk of heart attack, stroke and colon cancer.
Source: the Mail online | Health - April 11, 2016 Category: Consumer Health News Source Type: news

Task Force Releases Recommendations on Aspirin to Prevent Colon Cancer, Heart Disease
By Stacy SimonRESOURCES: Aspirin and Cancer Prevention: What the Research Really Shows The United States Preventive Services Task Force (USPSTF) has published new recommendations about aspirin to help prevent cardiovascular disease (heart attacks and strokes) and colorectal cancer (commonly called colon cancer).The USPSTF says people who are ages 50-59 years, who have at least a 10% risk of developing cardiovascular disease within the next 10 years, and who have no increased risk for bleeding should take low-dose aspirin regularly to help prevent heart attack, stroke, and colon cancer. Candidates should also have a l...
Source: American Cancer Society :: News and Features - April 11, 2016 Category: Cancer & Oncology Tags: Colon/Rectum Cancer Source Type: news

Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the U.S. Preventive Services Task Force.
Conclusion: Lifetime aspirin use for primary prevention initiated at younger ages (40 to 69 years) and in persons with higher CVD risk shows the greatest potential for positive net benefit. Primary Funding Source: Agency for Healthcare Research and Quality. PMID: 27064573 [PubMed - as supplied by publisher]
Source: Annals of Internal Medicine - April 11, 2016 Category: Internal Medicine Authors: Dehmer SP, Maciosek MV, Flottemesch TJ, LaFrance AB, Whitlock EP Tags: Ann Intern Med Source Type: research

Pop a daily aspirin to help prevent heart attacks, stroke and colon cancer, expert panel says
Taking a daily dose of aspirin can help prevent both heart disease and colorectal cancer in adults ages 50 to 69 who are at an increased risk for cardiovascular problems, an independent panel of medical experts said Monday. The final recommendation from the U.S. Preventive Services Task Force said that low-dose aspirin — typically, 81 mg […]
Source: Washington Post: To Your Health - April 11, 2016 Category: Consumer Health News Authors: Lena H. Sun Tags: health cancer Source Type: news

USPSTF publishes recommendation on taking aspirin to prevent heart attack, stroke, and colorectal cancer
(American College of Physicians) The US Preventive Services Task Force recommends that people who are 50-69 years old, have increased risk of cardiovascular disease (CVD), and who are not at increased risk for bleeding, consider taking aspirin for primary prevention of CVD and colorectal cancer. The full recommendation and evidence reviews are published in Annals of Internal Medicine.
Source: EurekAlert! - Cancer - April 11, 2016 Category: Cancer & Oncology Source Type: news

A Cost-Effectiveness Analysis Of Aspirin In The Primary Prevention Of Cardiovascular Diseases And Colorectal Cancer
This study aims to assess the cost-effectiveness of aspirin in the primary prevention of cardiovascular events (myocardial infarction (MI) and ischemic stroke (IS)) and colorectal cancer (CRC) in the low-risk general population in the United States (US).
Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: S Soon, WJ Chia, K Redekop, HL Wee Source Type: research

Panel recommends daily aspirin to prevent heart attack, colorectal cancer
Stephen FellerROCKVILLE, Md., Sept. 15 (UPI) -- A government task force suggests people between age 50 and 69 take aspirin every day to help prevent heart attack, stroke and colorectal cancer.
Source: Health News - UPI.com - September 15, 2015 Category: Consumer Health News Source Type: news

Pages: 1  2  3